Last 12 months
Inside the activity.
0 purchase rows · 57 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 16 |
| Dec 2025 | 0 | 12 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 12, 2019 Filed Aug 14, 2019 20:15 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.45 | $0.00 |
DisclosureSEC source: 0001384101-19-000108 · wf-form4_156581372426743.xml · derivative · entry 12 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,253 Underlying: Common Stock · 5,000 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. F4 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:15 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,667 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001384101-19-000108 · wf-form4_156581372426743.xml · derivative · entry 11 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,667 shares Expires 2025-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:15 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,243 | $0.00 Strike: $10.45 | $0.00 |
DisclosureSEC source: 0001384101-19-000108 · wf-form4_156581372426743.xml · derivative · entry 10 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,642 Underlying: Common Stock · 8,243 shares Expires 2024-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:15 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
SaleCommon Stock | 28,257 | $25.38 | $717,094.84 |
DisclosureSEC source: 0001384101-19-000108 · wf-form4_156581372426743.xml · nonDerivative · entry 7 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,037 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.12 to $25.94. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:15 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 4,406 | $5.98 | $26,347.88 |
DisclosureSEC source: 0001384101-19-000108 · wf-form4_156581372426743.xml · nonDerivative · entry 6 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,294 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:15 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 7,083 | $9.05 | $64,101.15 |
DisclosureSEC source: 0001384101-19-000108 · wf-form4_156581372426743.xml · nonDerivative · entry 5 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:15 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 1,563 | $5.43 | $8,487.09 |
DisclosureSEC source: 0001384101-19-000108 · wf-form4_156581372426743.xml · nonDerivative · entry 4 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:15 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 5,000 | $6.45 | $32,250.00 |
DisclosureSEC source: 0001384101-19-000108 · wf-form4_156581372426743.xml · nonDerivative · entry 3 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:15 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 1,667 | $8.86 | $14,769.62 |
DisclosureSEC source: 0001384101-19-000108 · wf-form4_156581372426743.xml · nonDerivative · entry 2 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:15 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 8,243 | $10.45 | $86,139.35 |
DisclosureSEC source: 0001384101-19-000108 · wf-form4_156581372426743.xml · nonDerivative · entry 1 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 20:24 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 15,000 | $26.38 | $395,680.50 |
DisclosureSEC source: 0001384101-19-000104 · wf-form4_156564147451154.xml · nonDerivative · entry 1 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by jVen Capital, LLC Disclosed balance after: 189,653 F1 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.13 to $26.61. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. F2 · ownership.nature: The Reporting Person is the sole managing member of jVen Capital, LLC. Read SEC document |
| August 02, 2019 Filed Aug 5, 2019 20:17 UTC |
Cohen Fred EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001384101-19-000102 · wf-form4_156503623993677.xml · derivative · entry 8 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2027-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 02, 2019 Filed Aug 5, 2019 20:17 UTC |
Cohen Fred EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001384101-19-000102 · wf-form4_156503623993677.xml · derivative · entry 7 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2026-06-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 02, 2019 Filed Aug 5, 2019 20:17 UTC |
Cohen Fred EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0001384101-19-000102 · wf-form4_156503623993677.xml · derivative · entry 6 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 02, 2019 Filed Aug 5, 2019 20:17 UTC |
Cohen Fred EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $13.19 | $0.00 |
DisclosureSEC source: 0001384101-19-000102 · wf-form4_156503623993677.xml · derivative · entry 5 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 02, 2019 Filed Aug 5, 2019 20:17 UTC |
Cohen Fred EDirector
|
Exercise / conversionCommon Stock | 10,000 | $7.94 | $79,400.00 |
DisclosureSEC source: 0001384101-19-000102 · wf-form4_156503623993677.xml · nonDerivative · entry 4 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 5, 2019 20:17 UTC |
Cohen Fred EDirector
|
Exercise / conversionCommon Stock | 10,000 | $5.28 | $52,800.00 |
DisclosureSEC source: 0001384101-19-000102 · wf-form4_156503623993677.xml · nonDerivative · entry 3 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 5, 2019 20:17 UTC |
Cohen Fred EDirector
|
Exercise / conversionCommon Stock | 10,000 | $10.41 | $104,100.00 |
DisclosureSEC source: 0001384101-19-000102 · wf-form4_156503623993677.xml · nonDerivative · entry 2 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 5, 2019 20:17 UTC |
Cohen Fred EDirector
|
Exercise / conversionCommon Stock | 10,000 | $13.19 | $131,900.00 |
DisclosureSEC source: 0001384101-19-000102 · wf-form4_156503623993677.xml · nonDerivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2019 Filed Jul 11, 2019 21:02 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000096 · wf-form4_156287891380081.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 8,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 10, 2019 Filed Jul 11, 2019 21:02 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 147 | $29.41 | $4,323.68 |
DisclosureSEC source: 0001384101-19-000096 · wf-form4_156287891380081.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,955 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $29.40 to $29.44. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 10, 2019 Filed Jul 11, 2019 21:02 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 7,853 | $28.78 | $225,990.49 |
DisclosureSEC source: 0001384101-19-000096 · wf-form4_156287891380081.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,102 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.40 to $29.39. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 10, 2019 Filed Jul 11, 2019 21:02 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 8,000 | $2.68 | $21,440.00 |
DisclosureSEC source: 0001384101-19-000096 · wf-form4_156287891380081.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| July 01, 2019 Filed Jul 1, 2019 21:10 UTC |
Kennedy KeithCOO / CFO
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000094 · wf-form4_156201539064647.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,211 F1 · shares: Restricted stock units awarded on July 1, 2019 vest 25% on July 1, 2020 and 1/16 on each quarterly vesting date thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 20:43 UTC |
JONES EVAN/ FADirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0001384101-19-000076 · wf-form4_156045858803088.xml · derivative · entry 1 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-11 F1 · derivative.exercise_date: The option becomes exercisable in full on June 12, 2020 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 20:50 UTC |
EPSTEIN ROBERT SDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0001384101-19-000082 · wf-form4_156045902027263.xml · derivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-11 F1 · derivative.exercise_date: The option becomes exercisable in full on June 12, 2020 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 20:45 UTC |
Nova Tina SusanDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0001384101-19-000078 · wf-form4_156045873091223.xml · derivative · entry 1 Nova Tina Susan · CIK 0001302605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-11 F1 · derivative.exercise_date: The option becomes exercisable in full on June 12, 2020 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 20:38 UTC |
EASTHAM KARINDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0001384101-19-000072 · wf-form4_156045830694990.xml · derivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-11 F1 · derivative.exercise_date: The option becomes exercisable in full on June 12, 2020 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 16:48 UTC |
BISHOP JOHN LDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0001384101-19-000080 · wf-form4_156045888197425.xml · derivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-11 F1 · derivative.exercise_date: The option becomes exercisable in full on June 12, 2020 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 20:33 UTC |
GORDON KEVIN KDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0001384101-19-000070 · wf-form4_156045800947196.xml · derivative · entry 1 GORDON KEVIN K · CIK 0001218483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-11 F1 · derivative.exercise_date: The option becomes exercisable in full on June 12, 2020 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 20:40 UTC |
Cohen Fred EDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0001384101-19-000074 · wf-form4_156045843005070.xml · derivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-11 F1 · derivative.exercise_date: The option becomes exercisable in full on June 12, 2020 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:36 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000068 · wf-form4_156028538630084.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 8,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:36 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 8,000 | $26.33 | $210,635.20 |
DisclosureSEC source: 0001384101-19-000068 · wf-form4_156028538630084.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,955 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.05 to $26.52. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:36 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 8,000 | $2.68 | $21,440.00 |
DisclosureSEC source: 0001384101-19-000068 · wf-form4_156028538630084.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:21 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,125 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-19-000058 · wf-form4_155976608887268.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,125 shares Expires 2021-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:21 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,526 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-19-000058 · wf-form4_155976608887268.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,526 shares Expires 2020-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:21 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 18,125 | $2.36 | $42,775.00 |
DisclosureSEC source: 0001384101-19-000058 · wf-form4_155976608887268.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:21 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 7,526 | $2.36 | $17,761.36 |
DisclosureSEC source: 0001384101-19-000058 · wf-form4_155976608887268.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:23 UTC |
Hall Christopher MPresident and COO
|
Tax withholdingCommon Stock | 456 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000060 · wf-form4_155976622460250.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,258 F1 · shares: The reporting person is reporting the withholding of 456 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 918 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:21 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 988 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000058 · wf-form4_155976608887268.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,304 F1 · shares: The reporting person is reporting the withholding of 988 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:28 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Tax withholdingCommon Stock | 292 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000064 · wf-form4_155976652503137.xml · nonDerivative · entry 1 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,332 F1 · shares: The reporting person is reporting the withholding of 292 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 587 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:26 UTC |
Kennedy KeithChief Financial Officer
|
Tax withholdingCommon Stock | 339 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000062 · wf-form4_155976638468536.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,211 F1 · shares: The reporting person is reporting the withholding of 339 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 643 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. Read SEC document |
| May 10, 2019 Filed May 13, 2019 20:28 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000056 · wf-form4_155777927395659.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 8,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 10, 2019 Filed May 13, 2019 20:28 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 2,340 | $23.52 | $55,045.22 |
DisclosureSEC source: 0001384101-19-000056 · wf-form4_155777927395659.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,292 F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $23.34 to $23.74. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| May 10, 2019 Filed May 13, 2019 20:28 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 5,660 | $22.77 | $128,903.10 |
DisclosureSEC source: 0001384101-19-000056 · wf-form4_155777927395659.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,632 F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $22.34 to $23.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| May 10, 2019 Filed May 13, 2019 20:28 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 8,000 | $2.68 | $21,440.00 |
DisclosureSEC source: 0001384101-19-000056 · wf-form4_155777927395659.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:30 UTC |
Hall Christopher MPresident and COO
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,506 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · derivative · entry 8 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,688 Underlying: Common Stock · 8,506 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F6 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:30 UTC |
Hall Christopher MPresident and COO
|
Exercise / conversionStock Option (right to buy) · Derivative | 63,746 | $0.00 Strike: $6.45 | $0.00 |
DisclosureSEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · derivative · entry 7 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,254 Underlying: Common Stock · 63,746 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F5 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:30 UTC |
Hall Christopher MPresident and COO
|
Exercise / conversionStock Option (right to buy) · Derivative | 42,748 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · derivative · entry 6 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,252 Underlying: Common Stock · 42,748 shares Expires 2025-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:30 UTC |
Hall Christopher MPresident and COO
|
SaleCommon Stock | 86,220 | $25.44 | $2,193,272.98 |
DisclosureSEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · nonDerivative · entry 5 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,714 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.00 to $25.82. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.